EVA1A and glioblastoma: EVA1A acts as a regulator of programmed cell death, and Shen et al. indicates that EVA1A can inhibit the proliferation of GBM cells by inducing autophagy and apoptosis via inactivating the mTOR/RPS6KB1 signaling pathway [21].